Lincoln Pharmaceuticals Ltd.
Snapshot View

View in App

Prices View details >>

281.30 +5.10 ▲1.9%

29 September 2022, 02:44:56 PM
Volume: 10,261

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lincolnpharma.com
Market Cap 555.12 Cr.
Enterprise Value(EV) 538.07 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 33.29 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 8.33 Trailing Twelve Months Ending 2022-06
Industry PE 30.82 Trailing Twelve Months Ending 2022-06
Book Value / Share 223.61 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.24 Calculated using Price: 277.15
Dividend Yield 0.54 Period Ending 2022-03
No. of Shares Subscribed 2.00 Cr. 20,029,728 Shares
FaceValue 10
Company Profile
Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.85%
1 Week
-3.65%
1 Month
-0.78%
3 Month
-5.03%
6 Month
-9.58%
1 Year
-27.69%
2 Year
+8.23%
5 Year
+74.99%
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 10.83 14.32 19.49 17.29 16.63 19.75 17.67 18.32 17.35
Return on Capital Employed (%) 11.48 15.91 21.18 18.51 19.05 22.50 22.30 24.90 24.29
Return on Assets (%) 4.10 5.77 8.87 9.40 10.09 12.80 12.33 13.48 13.31

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 89 99 111 141 192 224 269 313 366 433
Non Curr. Liab. 25 26 33 34 32 25 28 43 26 11
Curr. Liab. 118 131 114 100 99 113 100 80 95 111
Minority Int. 4 4 3 0 0 0 0 0
Equity & Liab. 237 260 262 275 324 363 399 437 487 555
Non Curr. Assets 114 111 81 128 134 136 159 174 160 182
Curr. Assets 123 149 181 147 190 227 239 263 328 373
Misc. Exp. not W/O
Total Assets 237 260 262 275 324 363 399 437 487 555

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 210 266 400 360 361 366 386 424 472 473
Other Income 2 7 7 3 5 6 11 6 10 14
Total Income 213 273 408 363 366 372 398 430 482 488
Total Expenditure -190 -240 -360 -314 -308 -299 -321 -337 -377 -386
PBIDT 23 33 48 50 58 73 77 93 105 102
Interest -7 -8 -10 -7 -5 -4 -2 -2 -1 -1
Depreciation -4 -5 -5 -6 -6 -7 -7 -8 -8 -8
Taxation -2 -5 -9 -9 -12 -13 -16 -21 -27 -25
Exceptional Items
PAT 10 15 24 28 35 49 51 62 69 67
Minority Interest 0 0 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 11 15 24 28 35 49 51 62 69 67
Adjusted EPS 7 9 15 14 17 24 26 31 35 33

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -16 5 25 45 25 27 53 75 69 76
Cash Fr. Inv. -16 1 7 -42 -25 -12 -18 -31 -64 -78
Cash Fr. Finan. 29 -11 -32 -3 0 -11 -36 -38 -6 -3
Net Change -3 -4 -1 0 0 3 -1 7 -1 -5
Cash & Cash Eqvt 9 5 4 3 3 7 5 12 11 7

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 32.36 32.41 33.41 37.26 37.78 40.28 42.08 42.05 44.08
Public 67.64 67.59 66.59 62.74 62.22 59.72 57.92 57.95 55.92
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 08 Sep 2022
Newspaper Advertisements
Lincoln Pharmaceuticals Limited has informed the Exchange about Newspaper Advertisements
Wed, 07 Sep 2022
Annual General Meeting
Lincoln Pharmaceuticals Limited has informed the Exchange about Notice of 28TH Annual General Meeting to be held on 30-Sep-2022
Wed, 07 Sep 2022
Newspaper Advertisements
Lincoln Pharmaceuticals Limited has informed the Exchange about Newspaper Advertisements

Technical Scans View Details >>

Wed, 28 Sep 2022
Close Crossing Last Month Low Close Crossing Last Month Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
MFI Trending Down MFI Trending Down
CCI Oversold Zone CCI Oversold Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 220,222.96 938.35 +2.2%
Divi's Laboratories Ltd. 98,114.53 3,710.00 +0.2%
Cipla Ltd. 88,495.80 1,120.00 +2.1%
Dr. Reddy's Laboratories Ltd. 71,034.40 4,378.85 +2.6%
Apollo Hospitals Enterprise Ltd. 61,344.29 4,386.90 +2.8%
Torrent Pharmaceuticals Ltd. 50,536.67 1,540.00 +3.1%
Alkem Laboratories Ltd. 39,477.37 3,245.65 -1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.55 938.35 +2.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.60 3,710.00 +0.2%
Cipla Ltd. Consolidated 2022-06 35.56 1,120.00 +2.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.75 4,378.85 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.44 4,386.90 +2.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 63.09 1,540.00 +3.1%
Alkem Laboratories Ltd. Consolidated 2022-06 30.25 3,245.65 -1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.39 938.35 +2.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.89 3,710.00 +0.2%
Cipla Ltd. Consolidated 2022-06 4.12 1,120.00 +2.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.51 4,378.85 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.32 4,386.90 +2.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 7.91 1,540.00 +3.1%
Alkem Laboratories Ltd. Consolidated 2022-06 4.50 3,245.65 -1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 938.35 +2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,710.00 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,120.00 +2.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,378.85 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,386.90 +2.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,540.00 +3.1%
Alkem Laboratories Ltd. Consolidated 2022-03 0.30 3,245.65 -1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 938.35 +2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,710.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,120.00 +2.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,378.85 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,386.90 +2.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,540.00 +3.1%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,245.65 -1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 938.35 +2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,710.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,120.00 +2.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,378.85 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,386.90 +2.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,540.00 +3.1%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,245.65 -1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 938.35 +2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,710.00 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,120.00 +2.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,378.85 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,386.90 +2.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,540.00 +3.1%
Alkem Laboratories Ltd. Consolidated 2022-03 10,634.19 3,245.65 -1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 938.35 +2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,710.00 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,120.00 +2.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,378.85 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,386.90 +2.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,540.00 +3.1%
Alkem Laboratories Ltd. Consolidated 2022-03 1,680.32 3,245.65 -1.6%

FAQ's On Lincoln Pharmaceuticals Ltd.

What is Lincoln Pharma share price?
Can I buy Lincoln Pharma shares now?
What is the Dividend Yield of Lincoln Pharma?
What is the Market Cap of Lincoln Pharma?
What are the key metrics to analyse Lincoln Pharma?
What is the 52 Week High and Low of Lincoln Pharma?
What is the trend of Lincoln Pharma share price?